Christine Zedelmayer - Nov 16, 2021 Form 4 Insider Report for Equillium, Inc. (EQ)

Role
Sr. Vice President and COO
Signature
/s/ Christine Zedelmayer
Stock symbol
EQ
Transactions as of
Nov 16, 2021
Transactions value $
-$5,547
Form type
4
Date filed
11/17/2021, 02:27 PM
Previous filing
Jun 14, 2021
Next filing
Feb 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EQ Common Stock Options Exercise $20.4K +8.33K +9.21% $2.45 98.8K Nov 16, 2021 Direct F1
transaction EQ Common Stock Sale -$22.4K -4.08K -4.13% $5.49* 94.8K Nov 16, 2021 Direct F2, F3
transaction EQ Common Stock Options Exercise $36.8K +15K +15.83% $2.45 110K Nov 16, 2021 Direct F1
transaction EQ Common Stock Sale -$40.3K -7.35K -6.7% $5.49* 102K Nov 16, 2021 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EQ Employee Stock Option Options Exercise $0 -8.33K -16.67% $0.00 41.7K Nov 16, 2021 Common Stock 8.33K $2.45 Direct F4
transaction EQ Employee Stock Option Options Exercise $0 -15K -16.67% $0.00 75K Nov 16, 2021 Common Stock 15K $2.45 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option exercises reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 17, 2021.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2021. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.40 to $5.59, inclusive. The reporting person undertakes to provide to Equillium, Inc., any security holder of Equillium, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
F4 In accordance with Instruction 4 to this Form, Column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or expiration dates are not considered to be of the same "class."